MR imaging of multiple sclerosis: Comparison with clinical and CT examinations in 74 patients

J. J. Sheldon, R. Siddharthan, J. Tobias

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Magnetic resonance (MR) imaging, the latest test for evaluation of patients with multiple sclerosis (MS), was assessed against clinical evidence in 74 patients with definite or probable MS. MR imaging was positive in 55 (85%) of 65 patients with definite MS but in only one (11%) of nine patients with probable MS. The examination is most likely to be positive when the patient is classified clinically as having definite MS; when the disease is active and not in remission; and if the constellation of symptoms indicates a multiplicity of regions with neurologic dysfunction. The examination was most sensitive for detecting lesions in the cerebral hemispheres, the posterior fossa, and the cervical spinal cord, in that order; it did not detect any lesions in the optic nerves. The paraclinical tests and MR imaging were of equal sensitivity in detecting MS lesions, but the latter method was more specific in localization. Cerebrospinal fluid evaluation was slightly less sensitive than the other two tests. There was no correlation between MR imaging and these examinations. The authors conclude that MR imaging is more sensitive than computed tomography (CT), which was positive in 25% of 59 patients with definite MS; it is always positive when CT is positive; and it probably can replace CT in the diagnosis and follow-up of patients with MS.

Original languageEnglish
Pages (from-to)683-690
Number of pages8
JournalAmerican Journal of Neuroradiology
Volume6
Issue number5
StatePublished - Dec 1 1985
Externally publishedYes

Fingerprint

Multiple Sclerosis
Tomography
Magnetic Resonance Imaging
Cerebrum
Optic Nerve
Neurologic Manifestations
Cerebrospinal Fluid

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

MR imaging of multiple sclerosis : Comparison with clinical and CT examinations in 74 patients. / Sheldon, J. J.; Siddharthan, R.; Tobias, J.

In: American Journal of Neuroradiology, Vol. 6, No. 5, 01.12.1985, p. 683-690.

Research output: Contribution to journalArticle

Sheldon, J. J. ; Siddharthan, R. ; Tobias, J. / MR imaging of multiple sclerosis : Comparison with clinical and CT examinations in 74 patients. In: American Journal of Neuroradiology. 1985 ; Vol. 6, No. 5. pp. 683-690.
@article{f699ce9ad3524be89d4ee4492739a8b2,
title = "MR imaging of multiple sclerosis: Comparison with clinical and CT examinations in 74 patients",
abstract = "Magnetic resonance (MR) imaging, the latest test for evaluation of patients with multiple sclerosis (MS), was assessed against clinical evidence in 74 patients with definite or probable MS. MR imaging was positive in 55 (85{\%}) of 65 patients with definite MS but in only one (11{\%}) of nine patients with probable MS. The examination is most likely to be positive when the patient is classified clinically as having definite MS; when the disease is active and not in remission; and if the constellation of symptoms indicates a multiplicity of regions with neurologic dysfunction. The examination was most sensitive for detecting lesions in the cerebral hemispheres, the posterior fossa, and the cervical spinal cord, in that order; it did not detect any lesions in the optic nerves. The paraclinical tests and MR imaging were of equal sensitivity in detecting MS lesions, but the latter method was more specific in localization. Cerebrospinal fluid evaluation was slightly less sensitive than the other two tests. There was no correlation between MR imaging and these examinations. The authors conclude that MR imaging is more sensitive than computed tomography (CT), which was positive in 25{\%} of 59 patients with definite MS; it is always positive when CT is positive; and it probably can replace CT in the diagnosis and follow-up of patients with MS.",
author = "Sheldon, {J. J.} and R. Siddharthan and J. Tobias",
year = "1985",
month = "12",
day = "1",
language = "English",
volume = "6",
pages = "683--690",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "5",

}

TY - JOUR

T1 - MR imaging of multiple sclerosis

T2 - Comparison with clinical and CT examinations in 74 patients

AU - Sheldon, J. J.

AU - Siddharthan, R.

AU - Tobias, J.

PY - 1985/12/1

Y1 - 1985/12/1

N2 - Magnetic resonance (MR) imaging, the latest test for evaluation of patients with multiple sclerosis (MS), was assessed against clinical evidence in 74 patients with definite or probable MS. MR imaging was positive in 55 (85%) of 65 patients with definite MS but in only one (11%) of nine patients with probable MS. The examination is most likely to be positive when the patient is classified clinically as having definite MS; when the disease is active and not in remission; and if the constellation of symptoms indicates a multiplicity of regions with neurologic dysfunction. The examination was most sensitive for detecting lesions in the cerebral hemispheres, the posterior fossa, and the cervical spinal cord, in that order; it did not detect any lesions in the optic nerves. The paraclinical tests and MR imaging were of equal sensitivity in detecting MS lesions, but the latter method was more specific in localization. Cerebrospinal fluid evaluation was slightly less sensitive than the other two tests. There was no correlation between MR imaging and these examinations. The authors conclude that MR imaging is more sensitive than computed tomography (CT), which was positive in 25% of 59 patients with definite MS; it is always positive when CT is positive; and it probably can replace CT in the diagnosis and follow-up of patients with MS.

AB - Magnetic resonance (MR) imaging, the latest test for evaluation of patients with multiple sclerosis (MS), was assessed against clinical evidence in 74 patients with definite or probable MS. MR imaging was positive in 55 (85%) of 65 patients with definite MS but in only one (11%) of nine patients with probable MS. The examination is most likely to be positive when the patient is classified clinically as having definite MS; when the disease is active and not in remission; and if the constellation of symptoms indicates a multiplicity of regions with neurologic dysfunction. The examination was most sensitive for detecting lesions in the cerebral hemispheres, the posterior fossa, and the cervical spinal cord, in that order; it did not detect any lesions in the optic nerves. The paraclinical tests and MR imaging were of equal sensitivity in detecting MS lesions, but the latter method was more specific in localization. Cerebrospinal fluid evaluation was slightly less sensitive than the other two tests. There was no correlation between MR imaging and these examinations. The authors conclude that MR imaging is more sensitive than computed tomography (CT), which was positive in 25% of 59 patients with definite MS; it is always positive when CT is positive; and it probably can replace CT in the diagnosis and follow-up of patients with MS.

UR - http://www.scopus.com/inward/record.url?scp=0022263427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022263427&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0022263427

VL - 6

SP - 683

EP - 690

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 5

ER -